Cochrane Reviews - by sub-topics 'Peripheral Vascular Diseases'

Physical (1)

Ultrasound guided compression (1)

Surgical treatments (pre-, peri- or post-operatively) (12)

Alpha-agonists (0)

Anticoagulants (0)

ACE inhibitors (0)

Anaesthesia - techniques used (1)

General versus loco-regional anaesthesia for endovascular aneurysm repair (protocol stage)

Analgesics (0)

Antibiotics (1)

Antiplatelets (0)

Beta-agonists (0)

Beta-blockers (0)

Blood transfusion (0)

Calcium antagonists (0)

Care (medical) during surgery (1)

Cerebrospinal fluid drainage for thoracic and thoracoabdominal aortic aneurysm surgery

Catecholamines (0)

Cell saver - use of (0)

Cytoprotectants (0)

Cerebrospinal fluid drainage (1)

Cytochromes (factors affecting cytochrome system) (0)

Fluids (1)

Intravenous fluids for abdominal aortic surgery

Graft types (1)

Endovascular repair of abdominal aortic aneurysm (protocol stage)

H2 blockers (0)

Haemodilution (0)

Heparin agonists (0)

Hydration - optimal pre-operative (0)

Incision - types of (0)

IV nutrition (0)

Lumbar sympathectomy (0)

Optiate antagonists (0)

Prostaglandins (0)

Pre-operative factors (not drugs or hydration) (0)

Sedatives (0)

Surgical techniques (3)

Endovascular repair of abdominal aortic aneurysm (protocol stage)

Endovascular treatment for ruptured abdominal aortic aneurysm

Surgery for small asymptomatic abdominal aortic aneurysms

Surgery versus non-surgical treatment (3)

Endovascular repair of abdominal aortic aneurysm (protocol stage)

Surgery versus thrombolysis for initial management of acute limb ischaemia

Temperature (0)

Thromboxane antagonists (0)

Vasodilators (0)

Rehabilitation (0)

Acute limb ischaemia (5)

Prevention (0)

Treatment (5)

Medical treatments (1)

Anticoagulants (0)

Antibiotics (0)

Fibrinolytics (0)

Rheological agents (0)

Thrombolysis (1)

Surgical treatments (4)

Amputations (2)

Criteria for determining level of amputation (0)

Flaps used in amputation (1)

Surgical techniques (1)

Surgery versus thrombolysis for initial management of acute limb ischaemia

Treatments given pre-, peri- or post-operatively (including following list to 'Vasodilators') (0)

Analgesics (0)

Anaesthetics (0)

Antibiotics (0)

Antipsychotics (0)

Antiplatelets (0)

Compression dressings (0)

Dressings (0)

Electromyostimulation (0)

Fibrinolytics (0)

Prostaglandins (0)

Phototherapy (0)

Vasodilators (0)

Anaesthetics used during surgery (0)

Drugs used pre-, peri- or post-operatively (1)

Beta-blockers (1)

Beta-adrenergic blockers for perioperative cardiac risk reduction in patients undergoing vascular surgery (protocol stage)

Surgical revascularisation (0)

Surgical thrombectomy (1)

Drugs used during surgical thrombectomy (0)

Rehabilitation (0)

Prostheses (0)

Rehabilitation methods (0)

Amputation (2)

Prevention (0)

Treatment (1)

Flaps used in amputation (1)

Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation

Rehabilitation (1)

Aortic Dissection (1)

Endovascular versus conventional treatment for type B aortic dissection (protocol stage)

Aortic aneurysm, thoracic (3)

Treatment (3)

Cerebrospinal fluid drainage (1)

Cerebrospinal fluid drainage for thoracic and thoracoabdominal aortic aneurysm surgery

Surgical (2)

Thoracic stent graft versus surgery for thoracic aneurysm

Thoracic stent graft versus surgery for traumatic thoracic transection (protocol stage)

Critical limb ischaemia (45)

Prevention (0)

Treatment (45)

Lifestyle treatments (3)

Diet (1)

Lipid-lowering for peripheral arterial disease of the lower limb

Exercise (1)

Lipid-lowering for peripheral arterial disease of the lower limb

Lipid lowering (1)

Medical treatments (5)

Amino acids (0)

Anticoagulants (0)

Analgesics (0)

Antibiotics (0)

Antiplatelets (1)

Sarpogrelate for peripheral arterial disease (protocol stage)

Buflomedil (0)

Dextran (0)

Haemodialysate (0)

Energy rich phosphates (0)

Fibrinolytics (0)

Gene therapy (0)

Herbal preparations (0)

Lipid lowering (1)

Lipid-lowering for peripheral arterial disease of the lower limb

Metabolic activators (0)

Methyl xanthines (0)

Naftidrofuryl (1)

Intravenous naftidrofuryl for critical limb ischaemia

Prostaglandins (1)

Prostanoids for critical limb ischemia (protocol stage)

Pentoxifylline (0)

Rutosides (0)

Serotonin antagonists (0)

Stem cell transplantation (0)

Thrombolytics (1)

Angioplasty versus stenting for superficial femoral artery lesions

Thromboxane antagonists (0)

Vasodilators (0)

Vasospastic agents (0)

Surgical treatment (37)

Amputation (see 'Acute limb ischaemia' for details) (0)

Angioplasty (24)

Treatments/interventions during angioplasty (including following list to 'Prostaglandins') (3)

Angioplasty versus stenting for superficial femoral artery lesions

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Antibiotics (0)

Antiplatelets (0)

Buflomedil (0)

Haemostatic devices (0)

Oxygen supplementation (0)

Pre-operative drugs (0)

Prostaglandins (0)

Surgical techniques (including following list to 'Angioplasty versus other treatments') (4)

Atherectomy for peripheral arterial disease (protocol stage)

Angioplasty versus stenting for superficial femoral artery lesions

Primary stenting versus balloon angioplasty for stenotic and occlusive lesions of the iliac artery. (protocol stage)

Balloon dilatation (5)

Atherectomy for peripheral arterial disease (protocol stage)

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Primary stenting versus balloon angioplasty for stenotic and occlusive lesions of the iliac artery. (protocol stage)

Cryoplasty (1)

Angioplasty versus stenting for superficial femoral artery lesions

Closure techniques (0)

Laser recanalisation (1)

Atherectomy for peripheral arterial disease (protocol stage)

Guide wires (0)

Angipolasty versus other surgical techniques (4)

Atherectomy for peripheral arterial disease (protocol stage)

Endovascular stents for intermittent claudication

Angioplasty versus non-surgical treatments (1)

Angioplasty (versus non surgical management) for intermittent claudication

Treatments/interventions to prevent restenosis following angioplasty (including following list to 'Prostaglandins') (0)

Anticoagulants (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Anaesthetics (0)

Antiplatelets (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Brachytherapy (1)

Intravascular brachytherapy for peripheral vascular disease

Dextran (0)

Essential fatty acids (0)

Haemodilution (0)

Lipid lowering (0)

Other treatments/interventions (1)

Endovascular stents for intermittent claudication

Prostaglandins (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Atherectomy (including endarterectomy and thromboendarterectomy) (2)

Atherectomy for peripheral arterial disease (protocol stage)

Bypass surgery (2)

Interposition vein cuff for infragenicular prosthetic bypass graft (protocol stage)

Drugs used pre-, peri- or post-operatively (1)

Beta-adrenergic blockers for perioperative cardiac risk reduction in patients undergoing vascular surgery (protocol stage)

Spinal cord stimulation (2)

Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia

Stent insertion (4)

Angioplasty versus stenting for superficial femoral artery lesions

Atherectomy for peripheral arterial disease (protocol stage)

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Primary stenting versus balloon angioplasty for stenotic and occlusive lesions of the iliac artery. (protocol stage)

Surgical technique (1)

Interposition vein cuff for infragenicular prosthetic bypass graft (protocol stage)

Sympathectomy (1)

Sympathectomy for peripheral arterial disease (protocol stage)

Rehabilitation (0)

Chronic venous insufficiency (9)

Prevention (3)

Compression (1)

Prevention of venous insufficiency in a standing workers population (protocol stage)

Exercise (1)

Prevention of venous insufficiency in a standing workers population (protocol stage)

Work place intereventions (1)

Prevention of venous insufficiency in a standing workers population (protocol stage)

Treatment (6)

Lifestyle treatments (0)

Exercise (0)

Education (0)

Counselling (0)

Medical treatments (5)

Anticoagulants (0)

Calcium antagonists (0)

Fibrinolytics (0)

Flavonoids (1)

Horse chestnut seed extract for chronic venous insufficiency

Herbal preparations (2)

Non-steroidal anti-inflammatories (0)

Rheological agents (0)

Ruscus extracts (0)

Rutosides (1)

Steroids (0)

Thrombolytics (0)

Topical treatments (0)

Venoactive agents (1)

Surgery for deep venous incompetence

Physical treatments (0)

Compression treatments (0)

Leg elevation (0)

Surgical treatments (1)

Rehabilitation (0)

Heparin_induced thrombocytopenia (HIT) (1)

Prevention (1)

Medical prophylaxis (1)

Anticoagulants (1)

Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients (protocol stage)

Oedema (0)

Prevention (0)

Treatment (0)

Medical treatments (0)

Bradykinin antagonists (0)

Diuretics (0)

Herbal preparations (0)

Rutosides (0)

Saccharides (0)

Steroids (0)

Venoactive agents (0)

Physical treatments (0)

Compression (0)

Elevation of legs (0)

Rehablitation (0)

Peripheral arterial occlusive disease (PAOD) (80)

Prevention (0)

Treatment (80)

Lifestyle treatments (7)

Diet (2)

Lipid-lowering for peripheral arterial disease of the lower limb

Exercise (3)

Exercise for intermittent claudication

Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication

Lipid lowering (2)

Lipid-lowering for peripheral arterial disease of the lower limb

Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication

Medical treatments (28)

Amino acids (0)

Alpha blockers (0)

Angiogenesis (0)

Anticoagulants (2)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

ACE inhibitors (0)

Alcohol (0)

Antioxidants (1)

Vitamin E for intermittent claudication

Antiplatelets (4)

Antiplatelet agents for intermittent claudication (protocol stage)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Cilostazol for peripheral arterial disease

Sarpogrelate for peripheral arterial disease (protocol stage)

Bamethane sulphate (0)

Bradykin antagonists (0)

Beta-blockers (2)

Beta blockers for peripheral arterial disease

Beta-adrenergic blockers for perioperative cardiac risk reduction in patients undergoing vascular surgery (protocol stage)

Biguanides (0)

Blood pressure lowering drugs (0)

Buflomedil (1)

Buflomedil for intermittent claudication

Calcium antagonists (0)

Calcitonin (0)

Cerebral activator agents (0)

Chelation therapy (1)

Chelation therapy for atherosclerotic cardiovascular disease

Chemical sympathectomy (0)

Carbon dioxide (0)

Co-enzymes for vitamins (0)

Cytochromics (0)

Depropanox (0)

Dextran (0)

Essential fatty acids (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Energy rich phosphates (0)

Fibrinolytics (2)

Fibrinolytic agents for peripheral arterial occlusion (protocol stage)

Gene therapy (1)

Gene therapy for peripheral arterial disease (protocol stage)

Glucose metabolites (0)

Haemodialysate (0)

Haemodilution (0)

Herbal preparations (3)

Garlic for peripheral arterial occlusive disease

Ginkgo biloba for intermittent claudication

Padma 28 for intermittent claudication (protocol stage)

Homocysteine-lowering interventions (1)

Homocysteine lowering interventions for peripheral arterial disease and bypass grafts

Hypoglycaemic agents (oral) (0)

Ifenprodil (0)

Lipid lowering (2)

Lipid-lowering for peripheral arterial disease of the lower limb

Naftidrofuryl for intermittent claudication

Monoamine oxidase inhibitors (0)

Methyl blue (0)

Methyldopa (0)

Methyl xanthine (0)

Narcain antagonists (0)

Nerve block (0)

Naftidrofuryl (1)

Neuroleptics (0)

Oestrogens (0)

Oxygen supplementation (0)

Ozone treatment (0)

Pantetheine (0)

Prostaglandins (2)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Prostanoids for intermittent claudication

Pentoxifylline (2)

Cilostazol for peripheral arterial disease

Pentoxifylline for intermittent claudication (protocol stage)

Rheological agents (0)

Rutosides (0)

Serotonin antagonists (0)

Suphonylurea (0)

Testosterone (1)

Steroid sex hormones for lower limb atherosclerosis

Thrombolytics (1)

Topical treatments (0)

Trace elements (0)

Thromboxane antagonists (0)

Vasodilators (0)

Vasospastic agents (0)

Physical treatments (0)

Electromagnetic field (diapulse) (0)

Electromyostimulation (0)

Immersion therapy (0)

Massage treatment (0)

Intermittent suction pressure treatment (0)

Surgical treatments (41)

Amputation (see 'Acute limb ischaemia' for details) (1)

Angioplasty versus stenting for superficial femoral artery lesions

Angioplasty (see 'Critical limb ischaemia' for details) (21)

Surgical techniques (including following list to 'Angioplasty versus other treatments') (4)

Atherectomy for peripheral arterial disease (protocol stage)

Angioplasty versus stenting for superficial femoral artery lesions

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Balloon dilatation (6)

Atherectomy for peripheral arterial disease (protocol stage)

Balloon angioplasty versus medical therapy for hypertensive patients with renal artery obstruction

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Primary stenting versus balloon angioplasty for stenotic and occlusive lesions of the iliac artery. (protocol stage)

Cryoplasty (1)

Angioplasty versus stenting for superficial femoral artery lesions

Angioplasty versus other surgical techniques (5)

Atherectomy for peripheral arterial disease (protocol stage)

Endovascular stents for intermittent claudication

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Angioplasty versus non-surgical treatments (1)

Angioplasty (versus non surgical management) for intermittent claudication

Treatments/interventions to prevent restenosis following angioplasty (including following list to 'Prostaglandins') (1)

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Anticoagulants (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Antiplatelets (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Proastaglandins (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Atherectomy (including endarterectomy and thromboendarterectomy) (2)

Atherectomy for peripheral arterial disease (protocol stage)

Intravascular brachytherapy for peripheral vascular disease

Brachytherapy (1)

Bypass surgery (10)

Medical treatments/interventions pre-, peri- or post-operatively (including following list to 'Venoactive agents') (1)

Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery

Anticoagulants (1)

ACE inhibitors (0)

Anaesthesia (0)

Analgesics (0)

Antibiotics (1)

Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery

Antioxidants (0)

Antiplatelets (1)

Calcium antagonists (0)

Cholinergic agents (0)

Dextran (0)

Homocysteine-lowering interventions (1)

Homocysteine lowering interventions for peripheral arterial disease and bypass grafts

Intensive surveillance (0)

IV fluids (0)

Lipid lowering drugs (0)

Medical care during surgery (1)

Pentoxifylline (0)

Post-operative management (drains etc) (1)

Pre-operative hydration (0)

Pre-operative drugs (0)

Pre-operative factors (not drugs or hydration) (0)

Prostaglandins (0)

Temperature (0)

Thrombolysis (1)

Thromboxane antagonists (0)

Xanthine oxidase inhibitors (0)

Venoactive agents (0)

Surgical interventions (including following list to 'Types of sutures') (1)

Graft type for femoro-popliteal bypass surgery

Atherectomy of occluded bypass (0)

Thrombolysis with catheter (0)

Graft types (1)

Types of incision (0)

Lumbar sympathectomy (0)

Surgical techniques (0)

Types of sutures (0)

Spinal cord stimulation (1)

Angioplasty versus stenting for superficial femoral artery lesions

Stent insertion (4)

Atherectomy for peripheral arterial disease (protocol stage)

Endoluminal stents for superficial femoral and popliteal artery occlusions in patients with lower limb peripheral artery disease (protocol stage)

Primary stenting versus balloon angioplasty for stenotic and occlusive lesions of the iliac artery. (protocol stage)

Thrombolysis with catheter (1)

Infusion techniques for peripheral arterial thrombolysis

Lumbar sympathectomy (0)

Venesection (0)

Treatment of complications associated with PAOD (4)

Prevention of restenosis/re-occlusion after treatment (4)

Anticoagulants (1)

Angioplasty (versus non surgical management) for intermittent claudication

Antiplatelets (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Fibrinolytics (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Prostaglandins (1)

Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment

Medical treatments (0)

Anticoagulants (0)

Antiplatelets (0)

Beta-blockers (0)

Blood pressure lowering drugs (0)

Calcium antagonists (0)

Serotonin antagonists (0)

Surgical treatments (0)

Lumbar sympathectomy (0)

Rehabilitation (0)

Thromboembolism (117)

Deep vein thrombosis (DVT) related (59)

Diagnostic Test Accuracy (0)

Prevention (41)

Medical prophylaxis (24)

Anticoagulants (12)

Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair (protocol stage)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction)

Interventions for preventing venous thromboembolism following abdominal aortic surgery

Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy

Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients (protocol stage)

Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)

The role of twice versus three times daily heparin dosing for thromboembolism prophylaxis in general medical patients admitted to the hospital (protocol stage)

Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients (protocol stage)

Antioxidants (0)

Antithrombotics (4)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Antiplatelets (1)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients

Biguanides (0)

Calcium antagonists (0)

Chloroquine and derivatives (0)

Cyctotoxic/DNA reactive drugs (0)

Dextran (0)

Direct Thrombin Inhibitors (1)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Fibrinolytics (0)

Immunosuppressants (0)

Indirect Thrombin Inhibitors (1)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Method of administration (1)

Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)

Non-steroidal anti-inflammatories (0)

Oestrogens (0)

Pentasaccharides (3)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients

Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Polysaccharides (0)

Protease inhibitors (0)

Pentoxifylline (0)

Rheological agents (0)

Statins (0)

Steroid hormones (0)

Testosterone/anabolic steroids (0)

Vasodilators (0)

Vitamin K Antagonists (1)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Surgical prophylaxis (0)

Anaesthetic (0)

Cement (orthopaedic surgery) (0)

Catheter material (0)

Catheter location (0)

IV fluids (0)

Risk assessment (0)

Tourniquet (0)

Physical methods of prophylaxis (17)

Compression (stockings) (8)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients

Compression stockings for preventing deep vein thrombosis in airline passengers

Elastic compression stockings for prevention of deep vein thrombosis

Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy

Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis (protocol stage)

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients (protocol stage)

Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)

Elevation of bed/feet (1)

Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)

Electromyostimulation (1)

Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)

Exercise (1)

Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)

Mechanical prophylaxis (5)

Interventions for preventing venous thromboembolism following abdominal aortic surgery

Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients (protocol stage)

Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)

Mobilisation (1)

Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage (protocol stage)

Other methods of prophylaxis (0)

Risk assessment (0)

Treatment (18)

Medical treatment (18)

Anticoagulant monitoring (1)

Warfarin initiation nomograms for venous thromboembolism (protocol stage)

Anticoagulants (11)

Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism

Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism

Home versus in-patient treatment for deep vein thrombosis

Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism

Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)

Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism

Thrombolysis for acute deep vein thrombosis

Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients (protocol stage)

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism

Warfarin initiation nomograms for venous thromboembolism (protocol stage)

Antiplatelets (0)

Biguanides (0)

Fibrinolytics (1)

Thrombolysis for acute deep vein thrombosis

Location of treatment (1)

Home versus in-patient treatment for deep vein thrombosis

Method of administration (2)

Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)

Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism

Non-steroidal anti-inflammatories (1)

Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism

Pentasaccharides (0)

Polysaccharides (0)

Proteolytic enzymes (0)

Rheological agents (0)

Thrombolytics (1)

Thrombolysis for acute deep vein thrombosis

Surgical treatment (0)

Angioplasty (0)

Arterio-venous fistulae (0)

Filter insertion (0)

Surgical removal (0)

Thrombectomy (0)

Physical treatment (0)

Compression (0)

Mechanical treatment (0)

Idiopathic recurrent vein thrombosis (0)

Prevention (0)

Medical prophylaxis (0)

Anticoagulants (0)

Antiplatelets (0)

Biguanides (0)

Physical prophylaxis (0)

Compression (0)

Treatment (0)

Antiplatelets (0)

Not DVT related (6)

Prevention (5)

Anticoagulants (3)

Heparin-bonded catheters for prolonging the patency of central venous catheters in children

Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children (protocol stage)

Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)

Method of administration (1)

Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)

Non-steroidal anti-inflammatories (0)

Physical prevention methods (1)

Heparin-bonded catheters for prolonging the patency of central venous catheters in children

Treatment (1)

Anticoagulants (0)

Method of administration (1)

Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)

Non-steroidal anti-inflammatories (0)

Rehabilitation (0)

Post thrombotic syndrome (PTS) (7)

Prevention (4)

Medical prophylaxis (1)

Rutosides (1)

Rutosides for prevention of post thrombotic syndrome (protocol stage)

Physical methods of prophylaxis (3)

Compression (stockings) (1)

Non-pharmaceutical measures for prevention of post-thrombotic syndrome

Elevation of bed/feet (1)

Non-pharmaceutical measures for prevention of post-thrombotic syndrome

Mechanical prophylaxis (1)

Non-pharmaceutical measures for prevention of post-thrombotic syndrome

Treatment (3)

Compression (stockings) (1)

Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome

Mechanical treatment (1)

Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome

Medical (1)

Rutosides (1)

Rutosides for treatment of post-thrombotic syndrome (protocol stage)

Pulmonary Embolism (PE) (45)

Prevention (35)

Medical prophylaxis (26)

Anticoagulants (11)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Interventions for preventing venous thromboembolism following abdominal aortic surgery

Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy

Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients (protocol stage)

Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)

The role of twice versus three times daily heparin dosing for thromboembolism prophylaxis in general medical patients admitted to the hospital (protocol stage)

Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients (protocol stage)

Vena caval filters for the prevention of pulmonary embolism

Antiplatelet agents (1)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients

Antithrombotics (6)

Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair (protocol stage)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Vena caval filters for the prevention of pulmonary embolism

Direct Thrombin Inhibitors (1)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Indirect Thrombin Inhibitors (1)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Method of administration (1)

Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity (protocol stage)

Pentasaccharides (3)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients

Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Statins (0)

Vitamin K antagonists (2)

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement (protocol stage)

Vena caval filters for the prevention of pulmonary embolism

Physical methods of prophylaxis (8)

Compression (stockings) (4)

Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients

Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients (protocol stage)

Mechanical prophylaxis (4)

Interventions for preventing venous thromboembolism following abdominal aortic surgery

Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy

Pentasaccharides for the prevention of venous thromboembolism (protocol stage)

Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients (protocol stage)

Surgical intervention (1)

Filter insertion (1)

Vena caval filters for the prevention of pulmonary embolism

Treatment (10)

Medical treatment (9)

Anticoagulant monitoring (1)

Warfarin initiation nomograms for venous thromboembolism (protocol stage)

Anticoagulants (4)

Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism

Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism

Warfarin initiation nomograms for venous thromboembolism (protocol stage)

Fibrinolytics (1)

Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism

Method of administration (1)

Non-steroidal anti-inflammatories (1)

Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism

Pentasaccharides (0)

Thrombolytics (1)

Surgical treatment (1)

Thrombophilia testing for prevention of recurrent venous thromboembolism

Physical treatment (0)

Thrombophilia (1)

Treatment (1)

Thrombophlebitis (12)

Cannulation phlebitis (4)

Prevention (4)

Medical prevention methods (2)

Anticoagulants (2)

Heparin-bonded catheters for prolonging the patency of central venous catheters in children

Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children (protocol stage)

Analgesics (0)

Anti-inflammatories (0)

IV fluids (0)

Steroids (0)

Physical prevention methods (2)

Cannula - size of bore, length, material etc (1)

Heparin-bonded catheters for prolonging the patency of central venous catheters in children

Duration of cannulisation (0)

Equipment - set up, and delivery systems (0)

Location of cannula (0)

Optimum replacement indications (1)

Clinically indicated replacement versus routine replacement of peripheral venous catheters (protocol stage)

Treatment (0)

Medical treatments (0)

Anticoagulants (0)

Antiplatelets (0)

Biguanides (0)

Fibrinolytics (0)

Non-steroidal anti-inflammatories (0)

Rheological agents (0)

Rutosides (0)

Sedatives (0)

Serotonin antagonists (0)

Steroids (0)

Superficial thrombophlebitis (8)

Prevention (0)

Treatment (8)

Medical treatments (3)

Anticoagulants (1)

Treatment for superficial thrombophlebitis of the leg

Non steroidal anti-inflammatories (1)

Treatment for superficial thrombophlebitis of the leg

Topical (1)

Treatment for superficial thrombophlebitis of the leg

Physical (2)

Compression (1)

Treatment for superficial thrombophlebitis of the leg

Elevation (1)

Treatment for superficial thrombophlebitis of the leg

Surgical treatments (3)

Crossectomy (1)

Treatment for superficial thrombophlebitis of the leg

Ligation (1)

Treatment for superficial thrombophlebitis of the leg

Vein stripping (1)

Treatment for superficial thrombophlebitis of the leg

Ulcers (arterial and mixed) (2)

Prevention (0)

Treatment (2)

Medical treatments (2)

Anticoagulants (0)

Antibiotics (0)

Antiplatelets (0)

Bradykinin antagonists (0)

Calcium antagonists (0)

Cell suspensions (0)

Co-enzymes for vitamin function (0)

Dressings (1)

Dressings and topical agents for arterial leg ulcers

Energy rich phosphates (0)

Fibrinolytics (0)

Growth hormones (0)

Herbal preparations (0)

Levamisole (0)

Metabolic activators (0)

Naftidrofuryl (0)

Oygen supplementation (0)

Prostaglandins (0)

Polysaccharides (0)

Proteolytic enzymes (0)

Pentoxifylline (0)

Rheological agents (0)

Ruscus extracts (0)

Topical treatments (1)

Dressings and topical agents for arterial leg ulcers

Trace elements (0)

Vasodilators (0)

Venoactive agents (0)

Physical treatments (0)

Compression (eg Una's boot) (0)

Electromagnetic field therapy (0)

Electromyostimulation (0)

Phototherapy (0)

Spinal cord stimulation (0)

Ultrasound (0)

Surgical treatments (0)

Laser treatment (0)

Skin grafts (0)

Surgery (0)

Rehabilitation (0)

Vasculitis (10)

Kawasaki disease (7)

Treatment (7)

Immunoglobulin (3)

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

Salicylate for the treatment of Kawasaki disease in children

Steroid hormone treatment for Kawasaki disease in children (protocol stage)

Salicylate (3)

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

Salicylate for the treatment of Kawasaki disease in children

Steroid hormone treatment for Kawasaki disease in children (protocol stage)

Steroid (1)

Steroid hormone treatment for Kawasaki disease in children (protocol stage)

Wegener's granulomatosis (3)

Treatment (3)

Immunoglobulin (1)

Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis

Immunosuppressants (1)

Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis

Steroids (1)

Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis

Vasospastic disorders (Primary Raynaud's Phenomenon) (6)

Prevention (0)

Treatment (6)

Medical treatments (6)

Amino acids (0)

Alpha-agonists (0)

Alpha-blockers (0)

ACE inhibitors (1)

Adrenergic blockers (0)

Antiplatelets (0)

Beta-antagonists (0)

Beta-blockers (0)

Bradykin antagonists (0)

Buflomedil (0)

Calcium antagonists (1)

Calcium channel blockers for primary Raynaud's Phenomenon (protocol stage)

Dextran (0)

Essential fatty acids (0)

Naftidrofuryl (0)

Platelet aggregation inhibitors (1)

Prostaglandins (0)

Pentoxifylline (0)

Rheological agents (0)

Serotonin antagonists (1)

Thyroid hormone (0)

Topical applications (0)

Thromboxane antagonists (1)

Vasodilators (1)